Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Integris Medtech recalibrates proposed IPO, reducing fresh issue component from ₹925 crore to ₹600 crore

The revision reflects market volatility amid geopolitical developments, with the company prioritising debt reduction

Integris Medtech recalibrates proposed IPO, reducing fresh issue component from ₹925 crore to ₹600 crore

We haven't written up this one. Hindu BusinessLine has the full story — the link below goes straight to it.

Read the original at thehindubusinessline.com →

More in Finance & Markets

More from Thursday 22 October →